Statistics for IGM Biosciences (id:7997 IGMS)

Valuation metrics

Market cap

674.92M

Enterprise value

501.99M

Trailing P/E (ttm)

-1.89

Forward P/E

-4.73

PEG ratio

-4.73

Price/Sales (ttm)

231.29

Price/Book (mrq)

8.55

Enterprise Value/Revenue

172.03

Enterprise Value/EBITDA

-2.24

Overview

Shares outstanding

33.93M

Float

11.67M

Shares short

3.68M

% Held by insiders

0.35%

% Held by institutions

0.66%

Average volume (10 days)

275.01K

Average volume (90 days)

Price summary

52-Week low

4.72

52-Week high

22.50

52-Week change

42.86%

Beta

0.19

50-Day moving average

14.85

200-Day moving average

11.11

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

June 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-12,478.10%

Operational effectiveness

Return on assets

-37.38%

Return on equity

-132.11%

Income statement

Revenue (ttm)

0.05

Revenue per share (ttm)

0.05

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-223,952,992.00

Net income to common (ttm)

-219,843,008.00

Diluted EPS (ttm)

-3.57

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

218.79M

Total cash per share (mrq)

3.68

Total debt (mrq)

45.86M

Total Debt/Equity (mrq)

58.09

Current ratio (mrq)

522.30%

Book value per share (mrq)

1.33

Cash flow

Cash flow statement

-166,184,000.00

Levered free cash flow (LFCF)

-100,197,128.00